InvestorLens

BHC — BAUSCH HEALTH COMPANIES INC.

Public company

Sign in to save1 tracked investor reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying BHC?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong distribution · 0 buying vs 2 selling last quarter
2
Macro Tailwind
Macro conditions are mixed for this sector
53
Why? — Evidence & Confidence ▾

Of 2 tracked investors who changed their BHC position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Expansion regime).

Supporting evidence
  • +1 tracked investors reported holding BHC at their latest filing
Contradicting evidence — always shown
  • −2 tracked investors reduced or exited last quarter (0 reduced, 2 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 10/4/2026.

About BAUSCH HEALTH COMPANIES INC. (BHC)

BAUSCH HEALTH COMPANIES INC. (BHC) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Carl Icahn (Icahn Capital), valued at $368M. Across recent filings, tracked investors recorded 5 new positions, 3 increased, 6 reduced, and 5 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BHC

42
/100
Mixed Activity
Added / Increased8
Reduced6
Exited5
BearishBullish
Crowded Trade Score™

How many top investors track BHC

7
/100
Undiscovered
1investor

Only 1 tracked investor report this position.

UndiscoveredCrowded
151015+

BHC Ownership Composition

How BAUSCH HEALTH COMPANIES INC. is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
100% of tracked value
Institutions
1
tracked investors
Total Reported
$9.8M
combined 13F value
Types1
  • Multi-Strategy / Quant100.0%
Multi-Strategy / Quant(1)
100.0%

Tracked investors currently reporting BHC

4 tracked investors have since exited this position — listed separately below.

  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    2M
    Value
    $9.8M
    % Portfolio
    0.00%

Previously held BHC

These investors reported BHC in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Carl IcahnIcahn Capital34.7M$231.2MJun 30, 2025
Izzy EnglanderMillennium Management443.4K$3.6MDec 31, 2024
Howard MarksOaktree Capital Management1.3M$10.2MDec 31, 2024
Ray DalioBridgewater Associates247.8K$1.7MJun 30, 2024

Recent activity

Frequently asked questions

How many institutional investors hold BHC?
1 tracked institutional investor disclosed a position in BHC (BAUSCH HEALTH COMPANIES INC.) in their most recent 13F filing.
Who is the largest institutional holder of BHC?
Carl Icahn, Icahn Capital, holds the largest disclosed position in BHC, valued at $368M.
Did institutional ownership of BHC increase or decrease?
Across recent 13F filings, tracked investors recorded 5 new positions, 3 increased, 6 reduced, and 5 fully exited BHC.
Where does this BHC ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.